Concepedia

Author

Simone U. Dalm

Erasmus MCORCID

Also Known As

Dalm, Simone U., S. U. Dalm, S.U. Dalm, Simone Dalm, Simone U. Dalm

53

Publications

1.2K

Citations

20

H-Index

13

Concepts

All Affiliations

Erasmus MCErasmus University RotterdamNational Centre of Scientific Research "Demokritos"Erasmus MC Cancer InstituteUniversity Medical Center Utrecht
SU

About

Simone U. Dalm is an author at Erasmus MC specializing in medicine, drug discovery, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

37

2

Engineering

1

1

16

3

Biomolecular Engineering

1

1

21

4

Cell Biology

1

1

21

5

Pharmacology

1

1

16

Simone U. Dalm

×

19

Publications

793

Citations

16

H-Index

YearCitations

Comparison of the Therapeutic Response to Treatment with a <sup>177</sup>Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models

Simone U. Dalm, Julie Nonnekens, Gabriela N. Doeswijk,

Journal of Nuclear Medicine

2015

126

<sup>68</sup>Ga/<sup>177</sup>Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology

Simone U. Dalm, Ingrid L. Bakker, Erik de Blois,

Journal of Nuclear Medicine

2016

124

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

Eline A. M. Ruigrok, Nicole van Vliet, Simone U. Dalm,

European Journal of Nuclear Medicine and Molecular Imaging

2020

97

In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer

Simone U. Dalm, John W.M. Martens, Anieta M. Sieuwerts,

Journal of Nuclear Medicine

2015

61

DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells

Sanne R. Martens‐de Kemp, Simone U. Dalm, Fiona M.J. Wijnolts,

PLoS ONE

2013

45

Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy

Simone U. Dalm, Anieta M. Sieuwerts, Maxime P. Look,

Journal of Nuclear Medicine

2015

44

GRPr Antagonist <sup>68</sup>Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients

Ingrid L. Bakker, Alida Fröberg, Martijn B. Busstra,

Journal of Nuclear Medicine

2021

41

Progressive APOBEC3B mRNA expression in distant breast cancer metastases

Anieta M. Sieuwerts, Willemijne A.M.E. Schrijver, Simone U. Dalm,

PLoS ONE

2017

36

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

Aikaterini Kaloudi, Emmanouil Lymperis, Athina Giarika,

Molecules

2017

34

Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity

Eline A. M. Ruigrok, Marjolein Verhoeven, Mark Konijnenberg,

European Journal of Nuclear Medicine and Molecular Imaging

2022

31

Page 1